{
  "basic_info": {
    "symbol": "RYTM",
    "name": "Rhythm Pharmaceuticals Inc",
    "sector": "LIFE SCIENCES",
    "industry": "PHARMACEUTICAL PREPARATIONS",
    "country": "USA",
    "currency": "USD"
  },
  "market_data": {
    "market_cap": "5826838000",
    "shares_outstanding": "65989000",
    "52_week_high": "94.8",
    "52_week_low": "40.61",
    "50_day_ma": "72.33",
    "200_day_ma": "60.65"
  },
  "valuation_ratios": {
    "pe_ratio": "None",
    "peg_ratio": "None",
    "price_to_book": "307.78",
    "price_to_sales": "42.57",
    "ev_revenue": "41.39",
    "ev_ebitda": "-12.65"
  },
  "profitability_metrics": {
    "profit_margin": "-1.233",
    "operating_margin_ttm": "-1.437",
    "return_on_assets_ttm": "-0.513",
    "return_on_equity_ttm": "-1.502",
    "gross_profit_ttm": "122654000"
  },
  "financial_strength": {
    "revenue_ttm": "136863000",
    "revenue_per_share_ttm": "2.217",
    "quarterly_revenue_growth": "0.259",
    "quarterly_earnings_growth": "0",
    "book_value": "0.298",
    "diluted_eps_ttm": "-2.8"
  },
  "dividend_info": {
    "dividend_per_share": "None",
    "dividend_yield": "None",
    "dividend_date": "None",
    "ex_dividend_date": "None"
  },
  "technical_indicators": {
    "beta": "2.268",
    "analyst_target_price": "104.57",
    "trailing_pe": "-",
    "forward_pe": "-"
  }
}